This is a preview of subscription content, log in via an institution to check access.
References
FDA. Statement alerting patients and health care professionals of NDMA found in samples of ranitidine. Internet Document : 13 Sep 2019. Available from: URL: https://www.fda.gov/news-events/press-announcements/statement-alertingpatients-and-health-care-professionals-ndma-found-samples-ranitidine.
EMA. EMA to review ranitidine medicines following detection of NDMA. Internet Document : 13 Sep 2019. Available from: URL: https://www.ema.europa.eu/en/news/ema-review-ranitidine-medicines-following-detection-ndma.
EMA. EMA to provide guidance on avoiding nitrosamines in human medicines. Internet Document : 13 Sep 2019. Available from: URL: https://www.ema.europa.eu/en/news/ema-provide-guidance-avoiding-nitrosamines-human-medicines.
Health Canada. Health Canada assessing NDMA in ranitidine. Internet Document : 13 Sep 2019. Available from: URL: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/70989a-eng.php.
HSA - Health Sciences Authority. HSA Stops Supply of Eight Brands of Ranitidine Products in Singapore. Internet Document : 16 Sep 2019. Available from: URL: https://www.hsa.gov.sg/content/hsa/en/News_Events/HSA_Updates/2019/HSA-stops-supply8brandsRanitidine.html.
Rights and permissions
About this article
Cite this article
Nitrosamine impurity in ranitidine. Reactions Weekly 1772, 3 (2019). https://doi.org/10.1007/s40278-019-68130-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-68130-0